Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
The Journal of Neuroscience, April 1, 2003, 23(7):2634
Derangements of Hippocampal Calcium/Calmodulin-Dependent Protein
Kinase II in a Mouse Model for Angelman Mental Retardation Syndrome
Edwin J.
Weeber1,
Yong-Hui
Jiang2,
Ype
Elgersma3, 4,
Andrew W.
Varga1,
Yarimar
Carrasquillo1,
Sarah E.
Brown1,
Jill M.
Christian1,
Banefsheh
Mirnikjoo1,
Alcino
Silva3,
Arthur L.
Beaudet2, and
J. David
Sweatt1
1 Division of Neuroscience and 2 Department
of Molecular and Human Genetics, Baylor College of Medicine, Houston,
Texas 77030, 3 Department of Neurobiology, University of
California, Los Angeles, Medical Center, Los Angeles, California
90095-1763, and 4 Department of Neuroscience, Erasmus
University Rotterdam, 3000 DR Rotterdam, The Netherlands
Angelman syndrome (AS) is a disorder of human cognition
characterized by severe mental retardation and epilepsy. Recently,a
mouse model for AS (Ube3a maternal null mutation) was
developedthat displays deficits in both context-dependent learning andhippocampal long-term potentiation (LTP). In the present
studies,we examined the molecular basis for these LTP and learning
deficits.Mutant animals exhibited a significant increase in
hippocampalphospho-calcium/calmodulin-dependent protein kinase II
(CaMKII),specifically at sites Thr286 and
Thr305, with no corresponding change in the levels
of total CaMKII.In addition, mutants show a reduction in CaMKII
activity, autophosphorylationcapability, and total CaMKII associated
with postsynaptic density.These findings are the first to implicate
misregulation of CaMKIIas a molecular cause for the neurobehavioral
deficits in a humanlearningdisorder.
Key words:
Angelman syndrome; calcium/calmodulin-dependent
protein kinase II; long-term potentiation; postsynaptic density; protein phosphatase; autophosphorylation
Decreased Tonic Inhibition in Cerebellar Granule Cells Causes Motor Dysfunction in a Mouse Model of Angelman Syndrome.
K. Egawa, K. Kitagawa, K. Inoue, M. Takayama, C. Takayama, S. Saitoh, T. Kishino, M. Kitagawa, and A. Fukuda (2012)
Science Translational Medicine
4, 163ra157
|Abstract »|Full Text »|PDF »
Activity-Dependent Modulation of the Interaction between CaMKII{alpha} and Abi1 and Its Involvement in Spine Maturation.
Ca2+/Calmodulin-dependent Protein Kinase II{alpha} ({alpha}CaMKII) Controls the Activity of the Dopamine Transporter: IMPLICATIONS FOR ANGELMAN SYNDROME.
T. Steinkellner, J.-W. Yang, T. R. Montgomery, W.-Q. Chen, M.-T. Winkler, S. Sucic, G. Lubec, M. Freissmuth, Y. Elgersma, H. H. Sitte, et al. (2012)
J. Biol. Chem.
287, 29627-29635
|Abstract »|Full Text »|PDF »
Defective glucocorticoid hormone receptor signaling leads to increased stress and anxiety in a mouse model of Angelman syndrome.
S. K. Godavarthi, P. Dey, M. Maheshwari, and N. Ranjan Jana (2012)
Hum. Mol. Genet.
21, 1824-1834
|Abstract »|Full Text »|PDF »
Alterations in Intrinsic Membrane Properties and the Axon Initial Segment in a Mouse Model of Angelman Syndrome.
H. Kaphzan, S. A. Buffington, J. I. Jung, M. N. Rasband, and E. Klann (2011)
J. Neurosci.
31, 17637-17648
|Abstract »|Full Text »|PDF »
Increased Gene Dosage of Ube3a Results in Autism Traits and Decreased Glutamate Synaptic Transmission in Mice.
S. E. P. Smith, Y.-D. Zhou, G. Zhang, Z. Jin, D. C. Stoppel, and M. P. Anderson (2011)
Science Translational Medicine
3, 103ra97
|Abstract »|Full Text »|PDF »
Ras and Rap Signaling in Synaptic Plasticity and Mental Disorders.
R. L. Stornetta and J. J. Zhu (2011)
Neuroscientist
17, 54-78
|Abstract »|PDF »
Aberrant Calcium/Calmodulin-Dependent Protein Kinase II (CaMKII) Activity Is Associated with Abnormal Dendritic Spine Morphology in the ATRX Mutant Mouse Brain.
N. Shioda, H. Beppu, T. Fukuda, E. Li, I. Kitajima, and K. Fukunaga (2011)
J. Neurosci.
31, 346-358
|Abstract »|Full Text »|PDF »
Angelman Syndrome, a Genomic Imprinting Disorder of the Brain.
S. J. Chamberlain and M. Lalande (2010)
J. Neurosci.
30, 9958-9963
|Full Text »|PDF »
Autonomous CaMKII Can Promote either Long-Term Potentiation or Long-Term Depression, Depending on the State of T305/T306 Phosphorylation.
H. J. Pi, N. Otmakhov, D. Lemelin, P. De Koninck, and J. Lisman (2010)
J. Neurosci.
30, 8704-8709
|Abstract »|Full Text »|PDF »
Genomic imprinting of experience-dependent cortical plasticity by the ubiquitin ligase gene Ube3a.
Neuronal Death Resulting from Targeted Disruption of the Snf2 Protein ATRX Is Mediated by p53.
C. Seah, M. A. Levy, Y. Jiang, S. Mokhtarzada, D. R. Higgs, R. J. Gibbons, and N. G. Berube (2008)
J. Neurosci.
28, 12570-12580
|Abstract »|Full Text »|PDF »
Distinct Regulation of {beta}2 and {beta}3 Subunit-Containing Cerebellar Synaptic GABAA Receptors by Calcium/Calmodulin-Dependent Protein Kinase II.
C. M. Houston, A. M. Hosie, and T. G. Smart (2008)
J. Neurosci.
28, 7574-7584
|Abstract »|Full Text »|PDF »
Association of Protein Phosphatase 1{gamma}1 with Spinophilin Suppresses Phosphatase Activity in a Parkinson Disease Model.
A. M. Brown, A. J. Baucum, M. A. Bass, and R. J. Colbran (2008)
J. Biol. Chem.
283, 14286-14294
|Abstract »|Full Text »|PDF »
The Angelman syndrome ubiquitin ligase localizes to the synapse and nucleus, and maternal deficiency results in abnormal dendritic spine morphology.
S. V. Dindot, B. A. Antalffy, M. B. Bhattacharjee, and A. L. Beaudet (2008)
Hum. Mol. Genet.
17, 111-118
|Abstract »|Full Text »|PDF »
Emerging Roles for Ubiquitin and Protein Degradation in Neuronal Function.
Enriching the environment of {alpha}CaMKIIT286A mutant mice reveals that LTD occurs in memory processing but must be subsequently reversed by LTP.
S. L. Parsley, S. M. Pilgram, F. Soto, K. P. Giese, and F. A. Edwards (2007)
Learn. Mem.
14, 75-83
|Abstract »|Full Text »|PDF »
Differential Modulation of Ca2+/Calmodulin-dependent Protein Kinase II Activity by Regulated Interactions with N-Methyl-D-aspartate Receptor NR2B Subunits and {alpha}-Actinin.
A. J. Robison, R. K. Bartlett, M. A. Bass, and R. J. Colbran (2005)
J. Biol. Chem.
280, 39316-39323
|Abstract »|Full Text »|PDF »
Maternal disruption of Ube3a leads to increased expression of Ube3a-ATS in trans.
M. Landers, M. A. Calciano, D. Colosi, H. Glatt-Deeley, J. Wagstaff, and M. Lalande (2005)
Nucleic Acids Res.
33, 3976-3984
|Abstract »|Full Text »|PDF »
Interaction between Dinucleotide and Nicotinic Receptors in Individual Cholinergic Terminals.
M. Diaz-Hernandez, J. Sanchez-Nogueiro, J. Pintor, and M. T. Miras-Portugal (2004)
J. Pharmacol. Exp. Ther.
311, 954-967
|Abstract »|Full Text »|PDF »
Activity-Dependent Regulation of Calcium/Calmodulin-Dependent Protein Kinase II Localization.
H. Schulman (2004)
J. Neurosci.
24, 8399-8403
|Full Text »|PDF »
Protein Phosphatases and Calcium/Calmodulin-Dependent Protein Kinase II-Dependent Synaptic Plasticity.
R. J. Colbran (2004)
J. Neurosci.
24, 8404-8409
|Full Text »|PDF »
Mouse Genetic Approaches to Investigating Calcium/Calmodulin-Dependent Protein Kinase II Function in Plasticity and Cognition.
Y. Elgersma, J. D. Sweatt, and K. P. Giese (2004)
J. Neurosci.
24, 8410-8415
|Full Text »|PDF »